Brief: Avenue Therapeutics Announces Pricing Of $5.0 Million Public Offering
Oct 31 (Reuters) - Avenue Therapeutics Inc ATXI.O :
* AVENUE THERAPEUTICS ANNOUNCES PRICING OF $5.0 MILLION
PUBLIC
OFFERING
* PRICING OF ITS PUBLIC OFFERING OF AN AGGREGATE OF
16,633,400
UNITS AT A PUBLIC OFFERING PRICE OF $0.3006 PER UNIT
Source text for Eikon: ID:nGNXch4gBR
Further company coverage: ATXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fortress Biotech
See all newsFortress Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Fortress Biotech Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Fortress Biotech And Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
Fortress Biotech Q1 net income jumps on PRV sale
Brief: Journey Medical Corporation Secures Contract With Third Major Gpo For Emrosi